The Net Income von Alcon (ALC.SW) beträgt zum Feb 20, 2026 1.71 B USD. Im Vorjahr betrug The Net Income 1.53 B USD — eine Veränderung um 11.73% (höher).
Alcon Net Income
Net Income
1.71 BUSD
pages_kennzahlen_[key]_[isin]__0_label
11.73%
In 2026, Alcon's profit amounted to 1.71 B USD, a 11.73% increase from the 1.53 B USD profit recorded in the previous year.
The Alcon Net Income history
3 Years
10 Years
25 Years
Max
NET INCOME (B USD)
Date
NET INCOME (B USD)
Jan 1, 2016
-0.17
Jan 1, 2017
0.26
Jan 1, 2018
-0.23
Jan 1, 2019
-0.66
Jan 1, 2020
-0.53
Jan 1, 2021
0.38
Jan 1, 2022
0.34
Jan 1, 2023
0.97
Jan 1, 2024
1.02
Invalid Date
1.53
Invalid Date
1.71
Invalid Date
1.99
Invalid Date
2.25
Invalid Date
2.59
Invalid Date
2.79
| YEAR | NET INCOME (B USD) |
|---|---|
| 2031 est | - |
| 2030 est | 2.79 |
| 2029 est | 2.59 |
| 2028 est | 2.25 |
| 2027 est | 1.99 |
| 2026 est | 1.71 |
| 2025 est | 1.53 |
| 2024 | 1.02 |
| 2023 | 0.97 |
| 2022 | 0.34 |
| 2021 | 0.38 |
| 2020 | -0.53 |
| 2019 | -0.66 |
| 2018 | -0.23 |
| 2017 | 0.26 |
| 2016 | -0.17 |
Alcon Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2016
6.6 B USD
56 M USD
-170 M USD
Jan 1, 2017
6.79 B USD
100 M USD
256 M USD
Jan 1, 2018
7.15 B USD
199 M USD
-227 M USD
Jan 1, 2019
7.51 B USD
225 M USD
-656 M USD
Jan 1, 2020
6.83 B USD
-78 M USD
-531 M USD
Jan 1, 2021
8.29 B USD
930 M USD
376 M USD
Jan 1, 2022
8.72 B USD
524 M USD
335 M USD
Jan 1, 2023
9.46 B USD
1.18 B USD
974 M USD
Jan 1, 2024
9.91 B USD
1.35 B USD
1.02 B USD
Invalid Date
10.48 B USD
1.98 B USD
1.53 B USD
Invalid Date
11.25 B USD
2.24 B USD
1.71 B USD
Invalid Date
11.99 B USD
2.54 B USD
1.99 B USD
Invalid Date
12.59 B USD
2.9 B USD
2.25 B USD
Invalid Date
13.43 B USD
3.25 B USD
2.59 B USD
Invalid Date
14.19 B USD
3.55 B USD
2.79 B USD
Alcon stock margins
The Alcon margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alcon. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alcon.
3 Years
5 Years
10 Years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2016
47.45 %
0.85 %
-2.58 %
Jan 1, 2017
47.17 %
1.47 %
3.77 %
Jan 1, 2018
49.9 %
2.78 %
-3.17 %
Jan 1, 2019
48.69 %
3 %
-8.74 %
Jan 1, 2020
45.24 %
-1.14 %
-7.77 %
Jan 1, 2021
56.64 %
11.22 %
4.54 %
Jan 1, 2022
55.17 %
6.01 %
3.84 %
Jan 1, 2023
55.57 %
12.49 %
10.3 %
Jan 1, 2024
55.65 %
13.66 %
10.27 %
Invalid Date
55.65 %
18.91 %
14.62 %
Invalid Date
55.65 %
19.94 %
15.21 %
Invalid Date
55.65 %
21.21 %
16.62 %
Invalid Date
55.65 %
23.07 %
17.86 %
Invalid Date
55.65 %
24.19 %
19.25 %
Invalid Date
55.65 %
25.04 %
19.69 %
Alcon Aktienanalyse
What does Alcon do? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products.
The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians.
The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment.
Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision.
Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment.
Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon ist eines der beliebtesten Unternehmen auf Eulerpool.com.
Net Income Details
Understanding Alcon's Profit Margins
The profit margins of Alcon represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Alcon's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Alcon's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Alcon's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Alcon’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Alcon stock
Alcon has made 1.71 B USD this year.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Alcon
Our stock analysis for Alcon Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alcon Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.